Development of sustained release eudragit based matrix tablet of fluvastatin sodium microspheres
By: Kanojia, Neha
.
Contributor(s): Singh, S.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2021Edition: Vol.83(6), Nov-Dec.Description: 1229-1242p.Subject(s): PHARMACEUTICSOnline resources: Click here
In:
Indian journal of pharmaceutical sciencesSummary: The purpose of this research is to investigate the suitability of acquiring improved dissolution profile and
sustained release of Fluvastatin sodium to reduce dosage frequency via a novel combination of freeze dried
microspheres and Eudragit polymers-based matrix tablet technologies. Fluvastatin sodium microspheres
were prepared using polyvinyl pyrollidone K-30 and Poloxamer 407 through solvent evaporation via
freeze drying. We adopted a central composite design to examine the influence of independent variables
viz. drug:polymer (X1) and surfactant (X2) on the t 50 % (Y1), Q90 (Y2) and percentage drug content (Y3)
along with determination of an optimized composition for production of an optimal Fluvastatin sodium
microspheres. Design expert software illustrated that an optimized Fluvastatin sodium microspherescould
be achieved using 1:3.496 drug:polymer and 3.102 % poloxamer 407 which would illustrates t50 %
(36.33 min), Q90 (79.99 %) and percentage drug content (81.589 %). The mean diameter and polydispersity
index of Fluvastatin sodium microspheres using dynamic light scattering was found 0.78 μm and 0.287,
respectively. Sustained release tablet of optimized Fluvastatin sodium microspheres (Fluvastatin sodium
microspheres-sustained release tablet) was manufactured using Eudragit RS 100 and Eudragit RL 100
based granules by wet granulation technique. In vitro drug release kinetics studies were executed to assess
the drug release mechanism from optimized Fluvastatin sodium microspheres and Fluvastatin sodium
microspheres-sustained release tablet. The dissolution level of Fluvastatin sodium was 3.58-fold improved
wthin 2 h through the freeze dried microspheres. Fluvastatin sodium microspheres-sustained release
tablet showed sustained drug release over 24 h and was matched properly to Korsmeyer-Peppas model
with release exponent of 0.5318, which indicated drug release through diffusion and erosion mechanism.
Conclusively, it has been demonstrated that novel combination of freeze dried microspheres and their
Eudragit polymers-based matrix tablet techniques could find great potential for improving drug dissolution
and sustained release of water insoluble drugs along with reduced dosage frequency.
| Item type | Current location | Call number | Status | Date due | Barcode | Item holds |
|---|---|---|---|---|---|---|
Articles Abstract Database
|
School of Pharmacy Archieval Section | Not for loan | 2022-1244 |
The purpose of this research is to investigate the suitability of acquiring improved dissolution profile and
sustained release of Fluvastatin sodium to reduce dosage frequency via a novel combination of freeze dried
microspheres and Eudragit polymers-based matrix tablet technologies. Fluvastatin sodium microspheres
were prepared using polyvinyl pyrollidone K-30 and Poloxamer 407 through solvent evaporation via
freeze drying. We adopted a central composite design to examine the influence of independent variables
viz. drug:polymer (X1) and surfactant (X2) on the t 50 % (Y1), Q90 (Y2) and percentage drug content (Y3)
along with determination of an optimized composition for production of an optimal Fluvastatin sodium
microspheres. Design expert software illustrated that an optimized Fluvastatin sodium microspherescould
be achieved using 1:3.496 drug:polymer and 3.102 % poloxamer 407 which would illustrates t50 %
(36.33 min), Q90 (79.99 %) and percentage drug content (81.589 %). The mean diameter and polydispersity
index of Fluvastatin sodium microspheres using dynamic light scattering was found 0.78 μm and 0.287,
respectively. Sustained release tablet of optimized Fluvastatin sodium microspheres (Fluvastatin sodium
microspheres-sustained release tablet) was manufactured using Eudragit RS 100 and Eudragit RL 100
based granules by wet granulation technique. In vitro drug release kinetics studies were executed to assess
the drug release mechanism from optimized Fluvastatin sodium microspheres and Fluvastatin sodium
microspheres-sustained release tablet. The dissolution level of Fluvastatin sodium was 3.58-fold improved
wthin 2 h through the freeze dried microspheres. Fluvastatin sodium microspheres-sustained release
tablet showed sustained drug release over 24 h and was matched properly to Korsmeyer-Peppas model
with release exponent of 0.5318, which indicated drug release through diffusion and erosion mechanism.
Conclusively, it has been demonstrated that novel combination of freeze dried microspheres and their
Eudragit polymers-based matrix tablet techniques could find great potential for improving drug dissolution
and sustained release of water insoluble drugs along with reduced dosage frequency.
Click on an image to view it in the image viewer
There are no comments for this item.